.089, R2 alter = .02. Ancillary Analyses Further healthrelated covariatesThe pattern of benefits remained
Chemexpress .089, R2 transform = .02. Ancillary Analyses Additional healthrelated covariatesThe pattern of results remained the identical when we added relationships status, statin use, tamoxifin/aromatase inhibitor use, antidepressant use, and therapy…